{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T03:03:31Z","timestamp":1786676611620,"version":"build-2736575974"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1681\/asn.2013020134","type":"journal-article","created":{"date-parts":[[2013,10,3]],"date-time":"2013-10-03T21:58:17Z","timestamp":1380837497000},"page":"2034-2043","source":"Crossref","is-referenced-by-count":74,"title":["Protection of Glucagon-Like Peptide-1 in Cisplatin-Induced Renal Injury Elucidates Gut-Kidney Connection"],"prefix":"10.1681","volume":"24","author":[{"given":"Daisuke","family":"Katagiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Hamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousuke","family":"Negishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisei","family":"Noiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20230208","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1097\/01.ASN.0000014692.19351.52","article-title":"Refining predictive models in critically ill patients with acute renal failure.","volume":"13","author":"Mehta","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R2-15-20230208","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ki.2011.120","article-title":"Apoptosis and acute kidney injury.","volume":"80","author":"Havasi","year":"2011","journal-title":"Kidney Int"},{"key":"R3-15-20230208","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: Mode of cytotoxic action and molecular basis of resistance.","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"R4-15-20230208","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies.","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int"},{"key":"R5-15-20230208","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The biology of incretin hormones.","volume":"3","author":"Drucker","year":"2006","journal-title":"Cell Metab"},{"key":"R6-15-20230208","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection.","volume":"9","author":"During","year":"2003","journal-title":"Nat Med"},{"key":"R7-15-20230208","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1210\/endo.137.7.8770921","article-title":"Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor.","volume":"137","author":"Bullock","year":"1996","journal-title":"Endocrinology"},{"key":"R8-15-20230208","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/j.1476-5381.2011.01272.x","article-title":"Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats.","volume":"164","author":"Liu","year":"2011","journal-title":"Br J Pharmacol"},{"key":"R9-15-20230208","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.regpep.2007.10.001","article-title":"Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart.","volume":"146","author":"Sonne","year":"2008","journal-title":"Regul Pept"},{"key":"R10-15-20230208","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nm.3128","article-title":"GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure.","volume":"19","author":"Kim","year":"2013","journal-title":"Nat Med"},{"key":"R11-15-20230208","doi-asserted-by":"crossref","first-page":"F355","DOI":"10.1152\/ajprenal.00729.2010","article-title":"Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1.","volume":"301","author":"Crajoinas","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"R12-15-20230208","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.regpep.2006.12.016","article-title":"Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells.","volume":"141","author":"Schlatter","year":"2007","journal-title":"Regul Pept"},{"key":"R13-15-20230208","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.pharmthera.2006.11.007","article-title":"Mechanisms of action of glucagon-like peptide 1 in the pancreas.","volume":"113","author":"Doyle","year":"2007","journal-title":"Pharmacol Ther"},{"key":"R14-15-20230208","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1210\/en.2002-220405","article-title":"Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.","volume":"143","author":"Farilla","year":"2002","journal-title":"Endocrinology"},{"key":"R15-15-20230208","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1210\/en.2002-220897","article-title":"Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5\u2032-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway.","volume":"144","author":"Hui","year":"2003","journal-title":"Endocrinology"},{"key":"R16-15-20230208","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1074\/jbc.M209423200","article-title":"Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.","volume":"278","author":"Li","year":"2003","journal-title":"J Biol Chem"},{"key":"R17-15-20230208","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00125-002-0828-3","article-title":"Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db\/db mice.","volume":"45","author":"Wang","year":"2002","journal-title":"Diabetologia"},{"key":"R18-15-20230208","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1210\/en.2010-0115","article-title":"Minireview: Update on incretin biology: Focus on glucagon-like peptide-1.","volume":"151","author":"Brubaker","year":"2010","journal-title":"Endocrinology"},{"key":"R19-15-20230208","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1210\/en.2003-1147","article-title":"Glucagon-like peptide-1 and the islet beta-cell: Augmentation of cell proliferation and inhibition of apoptosis.","volume":"144","author":"Drucker","year":"2003","journal-title":"Endocrinology"},{"key":"R20-15-20230208","doi-asserted-by":"crossref","first-page":"F681","DOI":"10.1152\/ajprenal.00075.2012","article-title":"DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury.","volume":"303","author":"Glorie","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"R21-15-20230208","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc07-0228","article-title":"Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: Preclinical biology and mechanisms of action.","volume":"30","author":"Drucker","year":"2007","journal-title":"Diabetes Care"},{"key":"R22-15-20230208","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/j.1523-1755.2004.00567.x","article-title":"Radical scavenger edaravone developed for clinical use ameliorates ischemia\/reperfusion injury in rat kidney.","volume":"65","author":"Doi","year":"2004","journal-title":"Kidney Int"},{"key":"R23-15-20230208","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/ki.2008.106","article-title":"Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury.","volume":"73","author":"Negishi","year":"2008","journal-title":"Kidney Int"},{"key":"R24-15-20230208","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0167-5699(99)01486-3","article-title":"CD26, let it cut or cut it down.","volume":"20","author":"De Meester","year":"1999","journal-title":"Immunol Today"},{"key":"R25-15-20230208","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0167-5699(94)90316-6","article-title":"CD26: A surface protease involved in T-cell activation.","volume":"15","author":"Fleischer","year":"1994","journal-title":"Immunol Today"},{"key":"R26-15-20230208","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/1471-2407-10-193","article-title":"Expression and activity profiles of DPP IV\/CD26 and NEP\/CD10 glycoproteins in the human renal cancer are tumor-type dependent.","volume":"10","author":"Varona","year":"2010","journal-title":"BMC Cancer"},{"key":"R27-15-20230208","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ki.1997.348","article-title":"Immunodissection of the human proximal nephron: Flow sorting of S1S2S3, S1S2 and S3 proximal tubular cells.","volume":"52","author":"Helbert","year":"1997","journal-title":"Kidney Int"},{"key":"R28-15-20230208","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vph.2011.05.001","article-title":"Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1.","volume":"55","author":"Fadini","year":"2011","journal-title":"Vascul Pharmacol"},{"key":"R29-15-20230208","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/j.1523-1755.2005.00275.x","article-title":"Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury.","volume":"67","author":"T\u00f6gel","year":"2005","journal-title":"Kidney Int"},{"key":"R30-15-20230208","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clim.2008.08.016","article-title":"The innate immune response in ischemic acute kidney injury.","volume":"130","author":"Jang","year":"2009","journal-title":"Clin Immunol"},{"key":"R31-15-20230208","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1089\/scd.2011.0588","article-title":"Genetic modification of mesenchymal stem cells to overexpress CXCR4 and CXCR7 does not improve the homing and therapeutic potentials of these cells in experimental acute kidney injury.","volume":"21","author":"Gheisari","year":"2012","journal-title":"Stem Cells Dev"},{"key":"R32-15-20230208","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2009.02.013","article-title":"Synergy between CD26\/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction.","volume":"4","author":"Zaruba","year":"2009","journal-title":"Cell Stem Cell"},{"key":"R33-15-20230208","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1034\/j.1600-065X.2000.17715.x","article-title":"CXCR4: Chemokine receptor extraordinaire.","volume":"177","author":"Murdoch","year":"2000","journal-title":"Immunol Rev"},{"key":"R34-15-20230208","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1681\/ASN.2005010102","article-title":"A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity.","volume":"17","author":"Liu","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R35-15-20230208","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0091-3057(03)00154-0","article-title":"Behavioral effects of neuropeptide Y in F344 rat substrains with a reduced dipeptidyl-peptidase IV activity.","volume":"75","author":"Karl","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"R37-15-20230208","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1097\/HJH.0b013e32833bd21b","article-title":"Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients.","volume":"28","author":"Testa","year":"2010","journal-title":"J Hypertens"},{"key":"R38-15-20230208","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.ki.5002256","article-title":"The pathological role of Bax in cisplatin nephrotoxicity.","volume":"72","author":"Wei","year":"2007","journal-title":"Kidney Int"},{"key":"R39-15-20230208","doi-asserted-by":"crossref","first-page":"F1140","DOI":"10.1152\/ajprenal.00262.2004","article-title":"Role of p53 in cisplatin-induced tubular cell apoptosis: Dependence on p53 transcriptional activity.","volume":"287","author":"Jiang","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"R40-15-20230208","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1038\/sj.onc.1209440","article-title":"Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis.","volume":"25","author":"Jiang","year":"2006","journal-title":"Oncogene"},{"key":"R41-15-20230208","doi-asserted-by":"crossref","first-page":"25467","DOI":"10.1074\/jbc.M110.217216","article-title":"Protective effects of dipeptidyl peptidase-4 (DPP-4) inhibitor against increased \u03b2 cell apoptosis induced by dietary sucrose and linoleic acid in mice with diabetes.","volume":"286","author":"Shirakawa","year":"2011","journal-title":"J Biol Chem"},{"key":"R42-15-20230208","doi-asserted-by":"crossref","first-page":"E494","DOI":"10.1152\/ajpendo.00116.2011","article-title":"New gene targets for glucagon-like peptide-1 during embryonic development and in undifferentiated pluripotent cells.","volume":"301","author":"Sanz","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R43-15-20230208","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2337\/diabetes.54.1.146","article-title":"Glucagon-like peptide 1 can directly protect the heart against ischemia\/reperfusion injury.","volume":"54","author":"Bose","year":"2005","journal-title":"Diabetes"},{"key":"R44-15-20230208","doi-asserted-by":"crossref","first-page":"F137","DOI":"10.1152\/ajprenal.00064.2012","article-title":"Glucagon-like peptide 1 receptor stimulation increases GFR and suppresses proximal reabsorption in the rat.","volume":"304","author":"Thomson","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"R45-15-20230208","doi-asserted-by":"crossref","first-page":"F963","DOI":"10.1152\/ajprenal.00259.2012","article-title":"Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice.","volume":"303","author":"Rieg","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"R47-15-20230208","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.112.195115","article-title":"Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.","volume":"60","author":"Liu","year":"2012","journal-title":"Hypertension"},{"key":"R48-15-20230208","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ki.1989.100","article-title":"Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure.","volume":"35","author":"Conger","year":"1989","journal-title":"Kidney Int"},{"key":"R50-15-20230208","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/diabetes.49.5.741","article-title":"Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.","volume":"49","author":"Stoffers","year":"2000","journal-title":"Diabetes"},{"key":"R51-15-20230208","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/labinvest.2012.71","article-title":"3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor simvastatin ameliorates renal fibrosis through HOXA13\u2013USAG-1 pathway.","volume":"92","author":"Hamasaki","year":"2012","journal-title":"Lab Invest"},{"key":"R52-15-20230208","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1172\/JCI118681","article-title":"In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia.","volume":"97","author":"Noiri","year":"1996","journal-title":"J Clin Invest"},{"key":"R53-15-20230208","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ki.1994.277","article-title":"Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure models.","volume":"46","author":"Conger","year":"1994","journal-title":"Kidney Int"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201312000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:23:16Z","timestamp":1786130596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201312000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2013020134","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}